by John Whyte, MD, PhD.
Moss Rehabilitation Research Institute, Albert Einstein Healthcare Network, Philadelphia, Pennsylvania, USA.
Randomized double-blind placebo-controlled trials have been argued to provide the strongest test of efficacy and, as such, are important tools for advancing the evidence base supporting rehabilitation treatment. However, such trials present difficult ethical issues, because one group, by definition, receives [...]